Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 MEDICAL MARIJUANA MARKET, BY MEDICAL APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CHRONIC PAIN

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. MIGRAINE

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CANCER

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. ARTHRITIS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. OTHERS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

Chapter: 5 MEDICAL MARIJUANA MARKET, BY GEOGRAPHY

5.1. OVERVIEW
5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.2.4. North America Medical Marijuana Market by Medical Application

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. Germany market size and forecast
5.3.3.2. Spain market size and forecast
5.3.3.3. Italy market size and forecast
5.3.3.4. Netherlands market size and forecast
5.3.3.5. Russia market size and forecast
5.3.3.6. Switzerland market size and forecast
5.3.3.7. Rest of Europe market size and forecast

5.3.4. Europe Medical Marijuana Market by Medical Application

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. India market size and forecast
5.4.3.2. Australia market size and forecast
5.4.3.3. Rest of Asia-Pacific market size and forecast

5.4.4. Asia-Pacific Medical Marijuana Market by Medical Application

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. South Africa market size and forecast
5.5.3.2. Chile market size and forecast
5.5.3.3. Columbia market size and forecast
5.5.3.4. Israel market size and forecast
5.5.3.5. Turkey market size and forecast
5.5.3.6. Rest of LAMEA market size and forecast

5.5.4. LAMEA Medical Marijuana Market by Medical Application

Chapter: 6 COMPANY PROFILES

6.1. CARA THERAPEUTICS INC.

6.1.1. Operating business segments
6.1.2. Business performance
6.1.3. Key strategic moves and developments

6.2. CANOPY GROWTH

6.2.1. Operating business segments
6.2.2. Business performance
6.2.3. Key strategic moves and developments

6.3. INSYS THERAPEUTICS

6.3.1. Operating business segments
6.3.2. Business performance
6.3.3. Key strategic moves and developments

6.4. CANNAGROW HOLDINGS, INC.

6.4.1. Operating business segments
6.4.2. Business performance
6.4.3. Key strategic moves and developments

6.5. CANNABIS SATIVA, INC.

6.5.1. Operating business segments
6.5.2. Business performance
6.5.3. Key strategic moves and developments

6.6. ARENA PHARMACEUTICALS

6.6.1. Operating business segments
6.6.2. Business performance
6.6.3. Key strategic moves and developments

6.7. APHRIA

6.7.1. Operating business segments
6.7.2. Business performance
6.7.3. Key strategic moves and developments

6.8. GW PHARMACEUTICALS, PLC

6.8.1. Operating business segments
6.8.2. Business performance
6.8.3. Key strategic moves and developments

6.9. LEXARIA CORP

6.9.1. Operating business segments
6.9.2. Business performance
6.9.3. Key strategic moves and developments

6.10. INTERNATIONAL CONSOLIDATED COMPANIES, INC.

6.10.1. Operating business segments
6.10.2. Business performance
6.10.3. Key strategic moves and developments